New drug combo aims to knock out hepatitis b virus

NCT ID NCT05612581

Summary

This study tested several new drug combinations to see if they could safely control and potentially clear the hepatitis B virus in adults. It involved 33 people with chronic hepatitis B who had not taken certain standard treatments before. Researchers measured whether the virus became undetectable and if liver health improved during and after treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigative Site

    Clichy, 92110, France

  • Investigative Site

    Nice, 06200, France

  • Investigative Site

    Rennes, 35000, France

  • Investigative Site

    Toulouse, 31000, France

  • Investigative Site

    Hong Kong, Sha Tin, Hong Kong

  • Investigative Site

    Hong Kong, Hong Kong

  • Investigative Site

    Chisinau, MD 2025, Moldova

  • Investigative Site

    Bucharest, 021105, Romania

  • Investigative Site

    Busan, 49241, South Korea

  • Investigative Site

    Seoul, 5505, South Korea

  • Investigative Site

    Yangsan, 50612, South Korea

  • Investigative Site

    Glasgow, G4 0SF, United Kingdom

  • Investigative Site

    London, EC1A 7BE, United Kingdom

  • Investigative Site

    London, SE5 9RS, United Kingdom

  • Investigative Site

    Manchester, M8 5RB, United Kingdom

Conditions

Explore the condition pages connected to this study.